The company had posted a net profit of Rs 4.75 crore for the corresponding period of the previous fiscal, Hester Biosciences said in a filing to BSE.
Standalone net sales of the company also rose to Rs 28.52 crore for the quarter under consideration as against Rs 24.17 crore for the same period a year ago.
Nepal plant of the company has commenced commercial production on November 15, 2016, Hester Biosciences said.